GNW vs TECH · P/E 15, rev $7.29B vs P/E 65, rev $1.22B
Genworth Financial Inc (GNW) versus Bio-Techne Corp (TECH) — a side-by-side from cached financials, not a winner call.
Genworth Financial Inc (GNW) is a insurance - life company listed on US.
Bio-Techne Corp (TECH) is a biotechnology company listed on US.
Latest reported GNW revenue for 2024-12-31 was $7.29B. Net income was $427.0M. Revenue was up 281.7% from 2023-12-31 to 2024-12-31. GNW currently screens at market cap $3.24B and trailing P/E 14.8.
Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
GNW currently screens at market cap $3.24B and trailing P/E 14.8. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
Not investment advice. Open the GNW and TECH stock pages for the full models.
Not investment advice.